AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

TRAKM8 HOLDINGS PLC

Major Shareholding Notification May 16, 2025

7984_rns_2025-05-16_22a33c74-8969-4911-9bd6-f7c6ea160db7.html

Major Shareholding Notification

Open in Viewer

Opens in native device viewer

National Storage Mechanism | Additional information

RNS Number : 9022I

Trakm8 Holdings PLC

16 May 2025

FORM 8 (OPD)

PUBLIC OPENING POSITION DISCLOSURE BY A PARTY TO AN OFFER

Rules 8.1 and 8.2 of the Takeover Code (the "Code")

1.         KEY INFORMATION

(a) Full name of discloser: Trakm8 Holdings Plc
(b) Owner or controller of interests and short positions disclosed, if different from 1(a):

     The naming of nominee or vehicle companies is insufficient.  For a trust, the trustee(s), settlor and beneficiaries must be named.
N/A
(c) Name of offeror/offeree in relation to whose relevant securities this form relates:

     Use a separate form for each offeror/offeree
Trakm8 Holdings Plc
(d) Is the discloser the offeror or the offeree? Offeree
(e) Date position held:

     The latest practicable date prior to the disclosure
15 May 2025
(f)  In addition to the company in 1(c) above, is the discloser making disclosures in respect of any other party to the offer?

     If it is a cash offer or possible cash offer, state "N/A"
N/A

2.         POSITIONS OF THE PARTY TO THE OFFER MAKING THE DISCLOSURE

If there are positions or rights to subscribe to disclose in more than one class of relevant securities of the offeror or offeree named in 1(c), copy table 2(a) or (b) (as appropriate) for each additional class of relevant security.

(a)        Interests and short positions in the relevant securities of the offeror or offeree to which the disclosure relates

Class of relevant security: Ordinary Shares of 1 pence each
Interests Short positions
Number % Number %
(1) Relevant securities owned and/or controlled: Nil - Nil
(2) Cash-settled derivatives: Nil - Nil -
(3) Stock-settled derivatives (including options) and agreements to purchase/sell: Nil - Nil -
TOTAL: Nil - Nil -

All interests and all short positions should be disclosed.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

(b)        Rights to subscribe for new securities

Class of relevant security in relation to which subscription right exists: None
Details, including nature of the rights concerned and relevant percentages: N/A

3.         POSITIONS OF PERSONS ACTING IN CONCERT WITH THE PARTY TO THE OFFER MAKING THE DISCLOSURE

Details of any interests, short positions and rights to subscribe (including directors' and other employee options) of any person acting in concert with the party to the offer making the disclosure:

(A)  Ordinary shares of 1 pence each ("Ordinary Shares") held by directors of Trakm8 Holdings Plc and their close relatives:

Name Number of Ordinary Shares held % of Ordinary Shares held
John Watkins 7,768,7681 15.54
Timothy Cowley 2,268,127 2 4.53
Madeline Cowley 1,994,1163 3.99
Nadeem Raza 600,926 1.20
Keith Evans 381,119 0.76
Mark Watkins 318,310 0.63
Jonathan Edwards 4,418 0.00

1 This figure includes 1,370,714 Ordinary Shares that are held by Linda Watkins who is a close family member of John Watkins.

2 This figure includes 159,091 Ordinary Shares that are held by Anne Cowley who is a close family member of Timothy Cowley.

3 This figure includes 256,186 Ordinary Shares held by close family members of Madeline Cowley.

(B)  Options held over Trakm8 Holdings Plc's Ordinary Shares ("Options") by Trakm8 Holdings Plc directors, their close relatives and persons acting in concert2 :

Name Date of grant Number of Options outstanding Exercise price (£) Expiry date Vesting date
Nadeem Raza 24 July 2020 25,000 0.325 23 July 2030 24 July 20231
06 July 2023 25,000 0.17 04 July 2033 06 July 20261
John Watkins 05 March 2019 425,000 0.335 03 March 2029 04 March 20221
24 July 2020 100,000 0.325 23 July 2030 24 July 20231
Timothy Cowley 05 March 2019 50,000 0.335 03 March 2029 04 March 20221
27 November 2020 100,000 0.325 26 November 2030 27 November 20231
18 November 2021 50,000 0.27 18 November 2031 18 November 2024
Madeline Cowley 05 March 2019 25,000 0.335 03 March 2029 04 March 20221
27 November 2020 100,000 0.325 26 November 2030 27 November 20231
18 November 2021 75,000 0.27 18 November 2031 18 November 2024
Jonathan Edwards 05 March 2019 50,000 0.335 03 March 2029 04 March 20221
24 July 2020 25,000 0.20 23 July 2030 24 July 2023
18 November 2021 300,000 0.27 18 November 2031 18 November 2024
06 July 2023 150,000 0.17 04 July 2033 06 July 20261
Keith Evans 28 May 2019 125,000 0.335 26 May 2029 27 May 20221
27 November 2020 25,000 0.325 26 November 2030 27 November 20231
06 July 2023 75,000 0.17 04 July 2033 06 July 20261
Mark Watkins 05 March 2019 375,000 0.335 03 March 2029 04 March 20221
24 July 2020 100,000 0.325 23 July 2030 24 July 20231
27 November 2020 25,000 0.325 26 November 2030 27 November 20231
12 July 2021 300,000 0.16 11 July 2031 11 July 2024
06 July 2023 150,000 0.17 04 July 2033 06 July 20261

1 Exercise is subject to a performance target whereby the exercise of the Option is conditional on the Company's mid-market share price being £0.50 or higher at the time of exercise.

2 The exercise prices for all Options exceeds the offer price of £0.095 per Trakm8 Holdings Plc's Ordinary Shares.

(C)  Loan notes convertible into Trakm8 Holdings Plc's Ordinary Shares that are held by Trakm8 Holdings Plc directors, their close relatives and persons acting in concert :

Name Date of grant Number of Ordinary Shares to be issued on conversion1 Exercise price (£) Expiry date
Microlise Group Plc2 14 September 2022 (varied on 2 April 2024 and 11 April 2025) 12,345,679 0.081 13 September 2025
Nadeem Raza 2 April 2024 1,234,567 0.081 13 September 2025
John Watkins 14 September 2022 (varied on 2 April 2024 and 11 April 2025) 4,938,271 0.081 13 September 2025
2 April 2024 3,395,061 0.081 13 September 2025
Timothy Cowley 14 September 2022 (varied on 2 April 2024 and 11 April 2025) 740,740 0.081 13 September 2025
Madeline Cowley 14 September 2022 (varied on 2 April 2024 and 11 April 2025) 740,740 0.081 13 September 2025
Jonathan Edwards 2 April 2024 308,641 0.081 13 September 2025

1 Any accrued interest will be satisfied via a cash payment.

2 Nadeem Raza is a non-executive director of Trakm8 and owns 600,926 Trakm8 ordinary shares. Mr Raza is also Chief Executive of Microlise Group Plc ("Microlise") a company which also has its shares admitted to trading on AIM. Mr Raza owns 50.05% of the issued share capital of Microlise.

(D)  Interests of persons acting in concert with Trakm8 Holdings Plc (in addition to those set out in (A) above) in Trakm8 Holdings Plc's Ordinary Shares:

Name Number of ordinary

shares held
% of voting share capital
Microlise Group Plc1 10,000,000 20.010

1 Nadeem Raza is a non-executive director of Trakm8 and owns 600,926 Trakm8 ordinary shares. Mr Raza is also Chief Executive of Microlise Group Plc ("Microlise") a company which also has its shares admitted to trading on AIM. Mr Raza owns 50.05% of the issued share capital of Microlise.

Details of any open stock-settled derivative positions (including traded options), or agreements to purchase or sell relevant securities, should be given on a Supplemental Form 8 (Open Positions).

Details of any securities borrowing and lending positions or financial collateral arrangements should be disclosed on a Supplemental Form 8 (SBL).

4.         OTHER INFORMATION

(a)        Indemnity and other dealing arrangements

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the party to the offer making the disclosure or any person acting in concert with it:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"
None

(b)        Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between the party to the offer making the disclosure, or any person acting in concert with it, and any other person relating to:

(i)  the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"
None

(c)        Attachments

Are any Supplemental Forms attached?

Supplemental Form 8 (Open Positions) NO
Supplemental Form 8 (SBL) NO
###### Date of disclosure: 16 May 2025
###### Contact name: Jonathan Edwards, Chief Financial Officer
###### Telephone number: +44 330 333 4120

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service.

The Panel's Market Surveillance Unit is available for consultation in relation to the Code's disclosure requirements on +44 (0)20 7638 0129.

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk .

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [email protected] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

FEEUVVVRVSUVAAR

Talk to a Data Expert

Have a question? We'll get back to you promptly.